CAS 1531589-13-5

Brolucizumab

CAS : 1531589-13-5

Humanized single-chain antibody fragment targeting Vascular endothelial growth factor A (VEGFA)

Ref: 3D-CLA1382

Brolucizumab

CAS : 1531589-13-5

Brolucizumab (anti-VEGF-A scFv) potently blocks VEGF-A to reduce neovascularization in wet AMD, with picomolar binding affinity.

Degré de pureté : 95%

Couleur et forme : Liquid

Masse moléculaire : ~150 kDa

Ref: TM-T80593